GE Healthcare and Affidea, the pan-European leader in advanced diagnostic imaging, outpatient and cancer care services, have signed a multi-year agreement to deploy imaging and digital technologies across the Affidea network.
GE Healthcare will install 200+ new equipment in Affidea’s network of centers across Europe. The deal includes the provision of 60 new MRIs, 50 ultrasound devices, 40 CT scanners and 30 X-rays machines in the next 3 years. It also includes a six-year service contract.
In addition, Affidea expands its collaboration with GE Healthcare in pharmaceutical diagnostics in all its geographies, to include Clariscan, GE Healthcare’s new contrast media product, used in MRI exams.
With this partnership agreement, Affidea and GE Healthcare aim to complete the activation of Affidea’s fleet of imaging equipment as a data-driven, connected and networked functionality, to enable clinicians’ collaboration, enhance sub-specialization and support business leaders to measurably improve operations near real time.
Affidea will deploy PACS (Picture Archiving and Communication System) driven post-processing hubs with the latest technologies and performance analytics capabilities with imaging insights, using GE Healthcare’s Edison intelligence platform at scale.
GE Healthcare and Affidea will also combine their respective clinical education, lean and leadership development expertise using digital technologies to accelerate best practice adoption.
As leading diagnostic and digital technologies innovators, both GE Healthcare and Affidea are committed to continue co-developing diagnostic workflow solutions aimed at fostering value-based healthcare and promoting precision medicine along the care pathway.
“In the era of data-driven healthcare, the potential to make a positive impact on patients and doctors’ experience is impressive. Our goal is to support doctors and our operational teams for the benefit of our patients by using data analytics as a new way of orchestrating patient care and improving their experience. We are very happy that we could collaborate with GE Healthcare on this important project, which will accelerate the delivery of data-driven precision health.” – said Giuseppe Recchi, CEO of Affidea Group.
“As a leading provider of medical imaging and monitoring intelligent devices, we are delighted to be cooperating with Affidea to enable broader access to the latest digital healthcare and imaging technologies in hospitals across Europe.”- said Catherine Estrampes, President and CEO, GE Healthcare Europe.
About GE Healthcare
GE Healthcare is the $19.8 billion healthcare business of GE (NYSE: GE). As a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, the company helps improve outcomes more efficiently for patients, healthcare providers, researchers and life sciences companies around the world.
About Affidea Group
Affidea (www.affidea.com) is the leading European provider of diagnostic imaging, outpatient and cancer care services, operating in 273 centers across 16 countries in Europe. Affidea Group employs over 9400 professionals and performs more than 14 million diagnostic examinations every year. Affidea is the only healthcare provider that sits on the Imaging Board of IBM Watson and also at Microsoft Cloud. Due to its track record for patient safety, Affidea is the most awarded diagnostic imaging provider in Europe by the European Society of Radiology – over 50% of all the centers awarded on the Eurosafe Wall of Stars belong to Affidea. The company is owned by interests associated with the Bertarelli family which are advised by their business entreprise, Waypoint Capital.